Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and sale of pharmaceuticals. Its products include tumor drugs, antibacterial drugs, antifungal drugs, antiviral agents, digestive system agents, immune system agents, blood system agents, cardiovascular system agents, nervous system agents, electrolyte and acid-base balance and nutritional, liver disease auxiliary drugs, endocrinology system drugs, Chinese patent drugs, base large infusion, American ginseng, and active pharmaceutical ingredients. The company was founded on September 6, 1999 and is headquartered in Chongqing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company